Drug-resistant strains are becoming more common, raising concerns among health officials about limited treatment options.
Napo Pharmaceuticals seeks orphan drug designation for Mytesi to treat diarrhea in breast cancer patients with brain metastases undergoing targeted therapy. Mytesi, a plant-based drug, restores gut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results